The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...
The start of the trial marks an expansion of the firm's oncology pipeline, and the firm hopes mRNA-2808 will be the first of many T-cell engagers in its portfolio.
Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...
But more broadly, the technology could revolutionize many areas of ... The COVID-19 vaccines manufactured by Pfizer-BioNTech ...
The mRNA vaccines developed to fight COVID-19 during the pandemic "did have a very important impact in decreasing hospitalizations, severe pneumonia and death." ...
FRIDAY, Oct. 24, 2025 (HealthDay News) — The mRNA technology powering some COVID vaccines may hold a surprising benefit for ...
Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...
The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems ...
New research suggests Covid-19 mRNA vaccines offer benefits beyond viral protection. These vaccines may boost the immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback